Notice Concerning Issuance Price, etc. of New Shares Issued through the Introduction of Retirement-Type Stock Benefit Trust (J-ESOP), New Shares Issued Based on Post-Grant Stock Compensation (Restricted Stock Units (RSU)) System, and Past RSU-Based New Share Issuance

New Share Issuance through Introduction of Retirement-Type Stock Benefit Trust (J-ESOP)

Nexera Pharma Inc. has decided to issue 1,236,400 shares of common stock with a payment deadline of April 30, 2026, accompanying the introduction of a retirement-type stock benefit trust (J-ESOP) system for domestic employees announced on November 19, 2025. The issuance price is set at 1,011 JPY per share, totaling approximately JPY 1.25 billion. The planned allottee is The Japan Trustee Services Bank, Ltd. (Trust E Account), aiming to provide stock benefits to employees. This issuance represents approximately 1.37% dilution against the total issued shares of 90,496,735 shares, and no additional burden is anticipated.

New Share Issuance Based on Post-Grant Stock Compensation (RSU) System and Determination of Past Issuance Prices

At the same Board of Directors meeting, a resolution was made for new share issuance based on the RSU system for the 26th to 28th issuances, totaling 2,049,962 shares (planned). The payment deadline for the 26th issuance is June 1, 2027, with the issuance price already set at 1,011 JPY per share. The 27th and 28th issuances are scheduled for payment in 2028 and 2029 respectively, with the number of shares and issuance prices delegated to the Representative Executive Officer. The RSU system is introduced as an incentive for officers and qualified employees, with total planned issuances under the stock compensation scheme accounting for approximately 6.95% of total issued shares.